These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Mineral trioxide aggregate vs. formocresol in pulpotomized primary molars: a preliminary report. Eidelman E, Holan G, Fuks AB. Pediatr Dent; 2001; 23(1):15-8. PubMed ID: 11242724 [Abstract] [Full Text] [Related]
4. Comparison of mineral trioxide aggregate and formocresol as pulp medicaments for pulpotomies in primary molars. Noorollahian H. Br Dent J; 2008 Jun 14; 204(11):E20. PubMed ID: 18425074 [Abstract] [Full Text] [Related]
6. Comparative evaluation of formocresol and mineral trioxide aggregate in pulpotomized primary molars--2 year follow up. Airen P, Shigli A, Airen B. J Clin Pediatr Dent; 2012 Jun 14; 37(2):143-7. PubMed ID: 23534319 [Abstract] [Full Text] [Related]
7. Comparative evaluation of formocresol and mineral trioxide aggregate as pulpotomy agents in deciduous teeth. Srinivasan D, Jayanthi M. Indian J Dent Res; 2011 Jun 14; 22(3):385-90. PubMed ID: 22048576 [Abstract] [Full Text] [Related]
8. Clinical and Radiographic Evaluation of the Effectiveness of Formocresol, Mineral Trioxide Aggregate, Portland Cement, and Enamel Matrix Derivative in Primary Teeth Pulpotomies: A Two Year Follow-Up. Yildirim C, Basak F, Akgun OM, Polat GG, Altun C. J Clin Pediatr Dent; 2016 Jun 14; 40(1):14-20. PubMed ID: 26696101 [Abstract] [Full Text] [Related]
9. Mineral trioxide aggregate and formocresol pulpotomy of primary teeth: a 2-year follow-up. Ansari G, Ranjpour M. Int Endod J; 2010 May 14; 43(5):413-8. PubMed ID: 20518934 [Abstract] [Full Text] [Related]
10. Long-term evaluation of pulpotomy in primary molars using mineral trioxide aggregate or formocresol. Holan G, Eidelman E, Fuks AB. Pediatr Dent; 2005 May 14; 27(2):129-36. PubMed ID: 15926290 [Abstract] [Full Text] [Related]
11. Evaluation of the formocresol versus mineral trioxide aggregate primary molar pulpotomy: a meta-analysis. Peng L, Ye L, Tan H, Zhou X. Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Dec 14; 102(6):e40-4. PubMed ID: 17138165 [Abstract] [Full Text] [Related]
12. Mineral trioxide aggregate as pulp capping agent for primary teeth pulpotomy: 2 year follow up study. Subramaniam P, Konde S, Mathew S, Sugnani S. J Clin Pediatr Dent; 2009 Dec 14; 33(4):311-4. PubMed ID: 19725237 [Abstract] [Full Text] [Related]
13. Comparison of mineral trioxide aggregate and diluted formocresol in pulpotomized human primary molars: 42-month follow-up and survival analysis. Mettlach SE, Zealand CM, Botero TM, Boynton JR, Majewski RF, Hu JC. Pediatr Dent; 2013 Dec 14; 35(3):E87-94. PubMed ID: 23756301 [Abstract] [Full Text] [Related]
14. Assessment of a novel alternative to conventional formocresol-zinc oxide eugenol pulpotomy for the treatment of pulpally involved human primary teeth: diode laser-mineral trioxide aggregate pulpotomy. Saltzman B, Sigal M, Clokie C, Rukavina J, Titley K, Kulkarni GV. Int J Paediatr Dent; 2005 Nov 14; 15(6):437-47. PubMed ID: 16238654 [Abstract] [Full Text] [Related]
15. Success rates of mineral trioxide aggregate, ferric sulfate, and formocresol pulpotomies: a 24-month study. Erdem AP, Guven Y, Balli B, Ilhan B, Sepet E, Ulukapi I, Aktoren O. Pediatr Dent; 2011 Nov 14; 33(2):165-70. PubMed ID: 21703067 [Abstract] [Full Text] [Related]